Faculty profile

Peter Stirling

ResearcherTerry Fox LaboratoryUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Peter Stirling

Researcher

Terry Fox Laboratory

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2026.
Principal investigator on 12 research grants (9 CIHR, 3 NSERC), most recently in 2025.
Supervised 4 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Dna Damage Dna Repair Genome Instability Dna Replication Cancer Dominant Negative Homologous Recombination Nucleases

Latest papers

The UVA-induced single-base mutational signature of CX-5461 in human cells.
Nucleic acids research · 2026
Mapping of DDX11 genetic interactions defines sister chromatid cohesion as the major dependency.
G3 (Bethesda, Md.) · 2024
ATAD5 restricts R-loop formation through PCNA unloading and RNA helicase maintenance at the replication fork.
Nucleic acids research · 2020

All 3 publications

Latest funding

Identification of novel DNA nuclease inhibition strategies
CIHR · 2025 · Nominated PI
$948,600
Characterizing DNA repair deficient cancers benefiting from pol-z inhibition
CIHR · 2025 · Supervisor
$120,000
7th Canadian Symposium on Telomeres and Genome Integrity
CIHR · 2025 · Co-investigator
$10,000

All 19 grants and awards

Identification of novel DNA nuclease inhibition strategies

Nominated PICIHR2025Project Grant

Principal investigators: Stirling, Peter C

Keywords: Cancer; Dna Damage; Dna Repair; Dna Replication; Dominant Negative; Homologous Recombination; Medicinal Chemistry; Nucleases; Small Molecule Inhibitors; Yeast

$948,600

Characterizing DNA repair deficient cancers benefiting from pol-z inhibition

SupervisorCIHR2025DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Principal investigators: Cozma, Ecaterina

Keywords: Dna Damage Repair; Genome Instability; Synthetic Lethality; Translesion Synthesis Polymerases

$120,000

7th Canadian Symposium on Telomeres and Genome Integrity

Co-investigatorCIHR2025Planning and Dissemination Grants - Institute/Initiative Community Support

Principal investigators: Cobb, Jennifer A

Keywords: Aging; Canadian Scientific Symposium; Cancer; Carcinogens; Dna Damage Repair; Dna Replication And Mitosis; Genome Stability; Nuclear Organization; Rare Disease; Telomeres

$10,000

Development and application of novel FEN1 endonuclease inhibitors

Nominated PICIHR2024Project Grant

Principal investigators: Stirling, Peter C

Keywords: Biochemistry; Dna Repair; Fbxw7; Fen1; Glioblastoma; Homologous Recombination Deficiency; Small Molecule Inhibitor

$1,044,226

Identification of novel DNA nuclease inhibition strategies

Nominated PICIHR2024Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

Principal investigators: Stirling, Peter C

Keywords: Cancer; Dna Damage; Dna Repair; Dna Replication; Dominant Negative; Homologous Recombination; Nucleases; Yeast

$100,000

Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers

SupervisorCIHR2023Travel Awards - Institute Community Support

Principal investigators: White, Justin M

Keywords: Cancer Therapy; Chemoresistance; Dna Repair; Ics Travel Awards; Synthetic Lethality

$1,500

Dominant genetics of cohesin pathway proteins to kill cancer

Nominated PICIHR2022Project Grant

Principal investigators: Stirling, Peter C

Keywords: Dominant Genetics; Genome Instability; Missense Mutations; Mutational Scanning; Protein Trapping; Smc Atpases; Synthetic Lethality

$883,575

Molecular and Functional Genomic Characterization of G-quadruplex in Cancers with the Alternate Lengthening of Telomere (ALT) Mechanism

Co-investigatorCIHR2021Project Grant

Principal investigators: Wong, Judy M

Keywords: Alternate Lengthening Of Telomere; G-Quadruplexes; R-Loop; Synthetic Lethality; Terra

$948,600

Protein trapping for therapeutic targeting of WRN in cancers with microsatellite instability.

SupervisorCIHR2021Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Baillie, Katherine E

Keywords: Cancer Therapy; Crispr-Cas9; Dna Damage Response; Microsatellite Instability; Protein Trapping; Synthetic Lethality; Wrn Helicase

$105,000

Nuclear protein quality control mechanisms during genotoxic stress

Principal investigatorNSERC2020Discovery Grants Program - Individual

Principal investigators: Stirling, Peter

$348,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Peter Stirling

Research

Latest papers

Latest funding

The UVA-induced single-base mutational signature of CX-5461 in human cells.

Mapping of DDX11 genetic interactions defines sister chromatid cohesion as the major dependency.

ATAD5 restricts R-loop formation through PCNA unloading and RNA helicase maintenance at the replication fork.

Identification of novel DNA nuclease inhibition strategies

Characterizing DNA repair deficient cancers benefiting from pol-z inhibition

7th Canadian Symposium on Telomeres and Genome Integrity

Development and application of novel FEN1 endonuclease inhibitors

Identification of novel DNA nuclease inhibition strategies

Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers

Dominant genetics of cohesin pathway proteins to kill cancer

Molecular and Functional Genomic Characterization of G-quadruplex in Cancers with the Alternate Lengthening of Telomere (ALT) Mechanism

Protein trapping for therapeutic targeting of WRN in cancers with microsatellite instability.

Nuclear protein quality control mechanisms during genotoxic stress

Frequent collaborators

Jason Moffat

Lesley Seymour

John Hilton

Samuel Aparicio

Philip Hieter